This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2020-2026.
Company Filing History:
Years Active: 2020-2026
Title: Diego Copelli: Innovator in Aerosol Inhalation Technology
Introduction
Diego Copelli is a prominent inventor based in Parma, Italy. He has made significant contributions to the field of aerosol inhalation devices, holding a total of 6 patents. His work focuses on improving the delivery and efficacy of inhaled medications, which is crucial for patients with respiratory conditions.
Latest Patents
One of his latest innovations is an aerosol inhalation device that features an actuator for a pressurized metered dose inhaler. This device provides a significant reduction in the non-respirable coarse fraction of the emitted aerosol medicament impacting the oro-pharynx. As a result, it leads to fewer associated side effects and oral candidiasis in patients. The mouthpiece portion of the device has a central rounded opening of a well-defined width and distance from the nozzle aperture, along with a cylindrical recess aligned with the central longitudinal axis of both the mouthpiece and the nozzle channel.
Another notable patent is for a stable pressurized aerosol solution composition that combines glycopyrronium bromide and formoterol. This aerosol solution is intended for use with a pressurized metered dose inhaler and is stabilized by a selected amount of a mineral acid. The composition exhibits improved stability when contained in a can that is internally coated with a fluorinated ethylene propylene (FEP) polymer.
Career Highlights
Diego Copelli works at Chiesi Farmaceutici S.p.a., a company known for its commitment to developing innovative pharmaceutical solutions. His work at Chiesi has allowed him to focus on creating effective inhalation therapies that enhance patient outcomes.
Collaborations
Throughout his career, Diego has collaborated with notable colleagues, including Sauro Bonelli and Massimiliano Dagli Alberi. These collaborations have contributed to the advancement of aerosol technology and the development of new therapeutic solutions.
Conclusion
Diego Copelli's contributions to aerosol inhalation technology demonstrate his commitment to improving patient care through innovation. His patents reflect a deep understanding of the challenges faced by patients and a dedication to finding effective solutions.